Phone +44 (0) 1656 667997
Go back
  • TrakCel to build custom configured system for Medeor

    September 15, 2018

    TrakCel, a Cardiff-based cell and gene therapy supply chain tracking and orchestration system software developer, has announced it has been engaged to build a custom configured system for Medeor Therapeutics, a clinical stage biotechnology company dedicated to the discovery, development and commercialisation of personalised cellular immunotherapies engineered to reprogramme the immune system in order to improve outcomes in organ transplant recipients.

    Read More

  • TrakCel partner with Mustang Bio

    August 09, 2018

    TrakCel has announced a partnership with Mustang Bio to build a custom configured cellular supply chain tracking and orchestration platform. The platform will be used in the clinical development and commercialisation of Mustang’s CAR T therapies. Financial details of the partnership have not been disclosed.

    Read More

  • TrakCel to supply Northern Alliance

    April 26, 2018

    TrakCel has announced it will be the organisation responsible for tracking and documentation of cell and gene therapy products for the Northern Alliance Advanced Therapies Treatment Centre.

    Read More

  • £7.3m award brings advanced medical therapies to Wales

    March 21, 2018

    A recently formed health consortium, jointly led by the Welsh Blood Service (on behalf of NHS Wales) and the National Institute for Health Research Birmingham Biomedical Research Centre, has been awarded £7.3m of UK Government funding to ensure more people benefit from a new generation of breakthrough therapies.

    Read More

  • £1.4m awarded to commercialise Rexgenero cell therapy

    February 05, 2018

    TrakCel has announced a consortium including itself, the Cell and Gene Therapy Catapult, Rexgenero Ltd and Fisher Bioservices (part of Thermo Fisher Scientific) has secured funding of £1.4m from Innovate UK to lead an industrial research project.

    Read More

  • TrakCel announce partnership with Cell and Gene Therapy Catapult

    September 08, 2017

    TrakCel has announced a partnership agreement to incorporate its needle-to-needle supply chain management platform into the Cell and Gene Therapy Catapult’s large scale cell and gene therapy manufacturing centre. The manufacturing centre provides a state of the art GMP facility and support infrastructure to enable collaborators to carry out the large scale manufacture of cell and gene therapies as they progress towards commercial supply.

    Read More

  • TrakCel appoints new director

    May 31, 2017

    Cardiff-headquartered TrakCel, which develops software for cell and gene therapy companies, has appointed a new director.

    Read More

  • TrakCel appoints Joe Vitale as US Director

    May 02, 2017

    TrakCel has appointed a new director to support its expansion into the US.

    Read More


    October 18, 2016

    The funding from San Francisco-based Telegraph Hill Partners will support Trakcel's global growth activities.

    Read More

  • TrakCel announces new group Chief Executive Officer

    July 26, 2016

    Mr. Ravi Nalliah joins the company from PCI Services Inc. a US-headquartered global leader for drug development services and a trusted partner to the world’s largest and most successful pharmaceutical firms.

    Read More

  1. 1
  2. 2
  3. Next page

Contact Us

Ty Mawr, Pheasant Walk,
Clos-y-Talcen, Pen-y-Fai,
Bridgend, CF31 4DU

+44 (0) 1656 667997